Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
23 May 2013 | By Biogen Idec
Biogen Idec announced that Spyros Artavanis-Tsakonas, Ph.D., has been named the company’s Chief Scientific Officer...
List view / Grid view
News
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics
23 May 2013 | By GlaxoSmithKline
Funding will support development of drugs to fight antibiotic resistance and bioterrorism...
Sanofi appoints David Loew, Senior Vice President, Commercial Operations, Europe
23 May 2013 | By Sanofi
Sanofi is pleased to announce the appointment of David Loew, effective July 1st , 2013.
Merck provides update on Phase III clinical program for preladenant
23 May 2013 | By Merck
Merck provides update on Phase III clinical program for preladenant, the company’s investigational parkinson’s disease medicine...
Wireless pill bottle wins Healthcare Innovation World Cup
22 May 2013 | By Boehringer Ingelheim
AdhereTech receives $50,000 grand prize in global diabetes innovation challenge funded by Boehringer Ingelheim...
Roche presents new, fully automated lab solution at Europe’s largest diagnostics conference
22 May 2013 | By Roche
System improves efficiency and speed of blood sample testing in medical labs...
Italy’s pharma market slump: revenue decline to continue, warns GlobalData
21 May 2013 | By GlobalData
Italian pharmaceutical market value will continue to fall in the foreseeable future...
Biogen Idec submits application to FDA for approval of PLEGRIDY™ in multiple sclerosis
21 May 2013 | By Biogen Idec
EMA submission planned in the coming weeks...
EMA validates Gilead’s marketing application for sofosbuvir for the treatment of hepatitis C
21 May 2013 | By Gilead Sciences
Gilead Sciences announced that the company’s MAA for sofosbuvir...
Abbott announces CE Mark for world’s longest coronary drug eluting stent
21 May 2013 | By Abbott
Abbott announced CE Mark in Europe for the XIENCE Xpedition™ 48 Everolimus Eluting Coronary Stent System...
Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement
21 May 2013 | By Novartis
New global survey results...
Scientists identify molecular trigger for Alzheimer’s disease
20 May 2013 | By University of Cambridge
New research establishes nature of malfunction in protein molecules that can lead to onset of dementia...
Elan announces transactions: decisively transforming the company
20 May 2013 | By Elan Corporation
Elan Corporation announces a series of transactions designed to decisively transform and advance the company...
Verona Pharma: ATS Sunday poster presentations
20 May 2013 | By FTI Consulting
Clinical and pre-clinical data highlighting the significant bronchodilator activity of novel dual PDE3/4 inhibitor RPL554...
Novartis drug Afinitor® significantly extended time without disease progression in women with HER2 positive advanced breast cancer
17 May 2013 | By Novartis
Results of a pivotal Phase III trial...
